Drug comparisons
Pioglitazone vs Rosiglitazone
Pioglitazone vs Rosiglitazone comparison: Both are TZDs for type 2 diabetes reducing insulin resistance. Key differences in safety, CV effects, and warnings.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered for type 2 diabetes patients requiring a thiazolidinedione to reduce insulin resistance after or with metformin, especially with cardiovascular considerations.
Bottom line
Pioglitazone is often preferred over Rosiglitazone due to a more favorable cardiovascular profile in available data, though both carry notable risks.
All medication comparisons